RESEARCH TRIANGLE PARK, N.C., May 12, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (IRD) (Nasdaq: IRD), a clinical-stage biotechnology company developing gene therapies for the treatment of inherited ...
Opus Genetics, Inc., a clinical-stage biotechnology company focusing on gene therapies for inherited retinal diseases, announced upcoming presentations at various scientific conferences in May 2025.
A second pediatric patient was recently dosed, and the pediatric cohort is expected to complete enrollment in Q2 2025; initial data from all three patients anticipated in Q3 2025 FDA Type D meeting ...
Opus Genetics is a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic disorders ...
Parents' genes -- even when not directly inherited by a child -- may play a role in their educational and mental health outcomes, finds a new report. Parents' genes -- even when not directly inherited ...
Discover interesting facts about how traits are passed down over generations through DNA. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.
When people ask "is cancer a genetic disease?" they are often thinking about family history: if my parent had cancer, will I? The short answer is complicated but important: cancer is driven by genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results